A zero-price warrant option could add shares following China SXT (SXTC)'s completed offering.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
China SXT Pharmaceuticals, Inc. (SXTC) successfully completed a registered direct offering of 8 million units at Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context